Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults [Phase 3]
Regeneron is conducting a Phase 3 trial to compare REGN7508 to apixaban and enoxaparin for thromboprophylaxis after total knee arthroplasty;…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Glioblastoma Remote Monitoring and Care - Research Protocol [NA]
This document outlines a remote monitoring and care research protocol for patients with glioblastoma, including considerations for venous th…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: CLEANer Aspiration for Pulmonary Embolism [NA]
A clinical trial evaluating the CLEANer Aspiration System for pulmonary embolism has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor
A completed clinical trial evaluated a preventive therapy for postpartum venous thromboembolism in women with genetic risk factors (Factor V…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: JETi Lower Extremity Venous Thrombosis
Abbott Medical Devices announced completion of the JETi trial for lower extremity venous thrombosis, with results posted on 2026-04-03.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study) [NA]
A clinical trial update for the PEHF Study evaluating pulmonary embolism in patients with acute heart failure; the trial status is not yet r…
-
EMA approval · 2026-04-01EMA Authorised: Eliquis (apixaban) — Bristol-Myers Squibb / Pfizer EEIG
The EMA authorised Eliquis (apixaban) to prevent venous thromboembolism in patients undergoing arthroplasty, with Bristol-Myers Squibb/Pfize…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial [NA]
A multicenter randomized trial compares intermediate versus standard doses of enoxaparin for preventing venous thromboembolism in severe tra…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis [NA]
This clinical trial compares the ClotTriever System to anticoagulation for treatment of deep venous thrombosis within the venous thromboembo…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events
A clinical trial update evaluating whether CYP2C19 genetic testing can prognosticate long-term risk of major adverse cardiac and vascular ev…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use [NA]
A completed clinical trial from the University of Michigan evaluated prescriber-pharmacist collaborative care to improve evidence-based anti…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers [Phase 3]
Phase 3 trial update on treatment and secondary prevention of venous thromboembolism in adults with solid or hematologic cancers; the study …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis [NA]
GRACE is a clinical trial evaluating the use of compression stockings to support extended-duration pharmacological thromboprophylaxis in pat…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage [NA]
This clinical trial update indicates ongoing recruitment for a study evaluating the timing of venous thromboembolism prophylaxis in patients…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Aspiration Thrombectomy Using the Symphony or Prodigy System
A clinical trial update indicates recruitment is ongoing for evaluating aspiration thrombectomy with the Symphony and Prodigy systems for ar…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
A nationwide prospective cohort study assessing long-term surveillance in patients with venous thromboembolism, completed under the sponsors…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: PET Fibrin Imaging of DVT and PE [Phase 1]
Phase 1 trial evaluating a PET fibrin imaging agent for detecting deep vein thrombosis and pulmonary embolism was terminated, with results p…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Venous Thromboembolism and Chronic Pain After Major Limb Trauma
Clinical trial update on venous thromboembolism and chronic pain after major limb trauma, currently not recruiting.
-
EMA approval · 2026-03-13EMA Authorised: Pradaxa (dabigatran etexilate mesilate) — Boehringer Ingelheim International GmbH
EMA has authorised Pradaxa (dabigatran etexilate mesilate) for use in patients undergoing arthroplasty replacement and for prevention of ven…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens [Phase 4]
This entry describes a Phase 4 clinical trial evaluating Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese patients with EGFR-…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Anticoagulation in Patients With Venous Thromboembolism and Cancer
Pfizer-sponsored clinical trial evaluating anticoagulation in cancer patients with venous thromboembolism is currently active but not recrui…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management [NA]
Ain Shams University is recruiting a study to determine whether anti-Factor Xa levels can predict outcomes in burn patients and optimize man…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty [Phase 2]
This Phase 2 trial from the University of Miami is evaluating the optimal dosing of low-dose aspirin to prevent venous thromboembolism after…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery
The study evaluates effectiveness and cost-effectiveness of venous thromboembolism prevention strategies in gynecologic surgery and is curre…
-
EMA approval · 2026-03-05EMA Authorised: Inhixa (enoxaparin sodium) — Techdow Pharma Netherlands B.V.
The EMA authorised Inhixa (enoxaparin sodium) for the prevention and treatment of venous thromboembolism, with Techdow Pharma Netherlands B.…